| SARS-CoV-2 501Y. V2 escapes neutralization by South African COVID-19 donor plasma CK Wibmer, F Ayres, T Hermanus, M Madzivhandila, P Kgagudi, ... Nature medicine 27 (4), 622-625, 2021 | 1162 | 2021 |
| International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009 WK Roth, MP Busch, A Schuller, S Ismay, A Cheng, CR Seed, ... Vox Sanguinis 102 (1), 82-90, 2012 | 275 | 2012 |
| Blood transfusion safety in Africa: a literature review of infectious disease and organizational challenges EM Bloch, M Vermeulen, E Murphy Transfusion medicine reviews 26 (2), 164-180, 2012 | 196 | 2012 |
| SARS-CoV-2 501Y CK Wibmer, F Ayres, T Hermanus, M Madzivhandila, P Kgagudi, ... V2 escapes neutralization by South African COVID-19 donor plasma. bioRxiv …, 2021 | 190 | 2021 |
| Transmitted/founder and chronic subtype C HIV-1 use CD4 and CCR5 receptors with equal efficiency and are not inhibited by blocking the integrin α4β7 NF Parrish, CB Wilen, LB Banks, SS Iyer, JM Pfaff, JF Salazar-Gonzalez, ... PLoS pathogens 8 (5), e1002686, 2012 | 185 | 2012 |
| Impact of individual‐donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South … M Vermeulen, N Lelie, W Sykes, R Crookes, J Swanevelder, L Gaggia, ... Transfusion 49 (6), 1115-1125, 2009 | 165 | 2009 |
| Refinement of a viral transmission risk model for blood donations in seroconversion window phase screened by nucleic acid testing in different pool sizes and repeat test algorithms J Weusten, M Vermeulen, H van Drimmelen, N Lelie Transfusion 51 (1), 203-215, 2011 | 142 | 2011 |
| Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 … LH Ping, SB Joseph, JA Anderson, MR Abrahams, JF Salazar-Gonzalez, ... Journal of virology 87 (13), 7218-7233, 2013 | 125 | 2013 |
| ABO blood group and COVID‐19: a review on behalf of the ISBT COVID‐19 working group R Goel, EM Bloch, F Pirenne, AZ Al‐Riyami, E Crowe, L Dau, K Land, ... Vox sanguinis 116 (8), 849-861, 2021 | 119 | 2021 |
| Characterization of occult hepatitis B virus strains in South African blood donors JP Allain, D Belkhiri, M Vermeulen, R Crookes, R Cable, A Amiri, R Reddy, ... Hepatology 49 (6), 1868-1876, 2009 | 106 | 2009 |
| Hepatitis B virus transmission by blood transfusion during 4 years of individual‐donation nucleic acid testing in South Africa: estimated and observed window period risk M Vermeulen, C Dickens, N Lelie, E Walker, C Coleman, M Keyter, ... Transfusion 52 (4), 880-892, 2012 | 95 | 2012 |
| Features of recently transmitted HIV-1 clade C viruses that impact antibody recognition: implications for active and passive immunization C Rademeyer, B Korber, MS Seaman, EE Giorgi, R Thebus, A Robles, ... PLoS pathogens 12 (7), e1005742, 2016 | 88 | 2016 |
| Prevalence of anti-SARS-CoV-2 antibodies among blood donors in Northern Cape, KwaZulu-Natal, Eastern Cape, and Free State provinces of South Africa in January 2021. W Sykes, L Mhlanga, R Swanevelder, TN Glatt, E Grebe, C Coleman, ... Research Square, 2021 | 68 | 2021 |
| Detection of different categories of hepatitis B virus (HBV) infection in a multi‐regional study comparing the clinical sensitivity of hepatitis B surface antigen and HBV‐DNA … N Lelie, R Bruhn, M Busch, M Vermeulen, WC Tsoi, S Kleinman, ... Transfusion 57 (1), 24-35, 2017 | 68 | 2017 |
| The use of rapid diagnostic tests for transfusion infectious screening in Africa: a literature review CR Pruett, M Vermeulen, P Zacharias, C Ingram, CT Tagny, EM Bloch Transfusion Medicine Reviews 29 (1), 35-44, 2015 | 67 | 2015 |
| Sensitivity of individual‐donation and minipool nucleic acid amplification test options in detecting window period and occult hepatitis B virus infections M Vermeulen, C Coleman, J Mitchel, R Reddy, H van Drimmelen, T Ficket, ... Transfusion 53 (10pt2), 2459-2466, 2013 | 66 | 2013 |
| Epidemiology of human parvovirus 4 infection in sub-Saharan Africa CP Sharp, M Vermeulen, Y Nébié, CF Djoko, M LeBreton, U Tamoufe, ... Emerging infectious diseases 16 (10), 1605, 2010 | 61 | 2010 |
| Guidance for the procurement of COVID‐19 convalescent plasma: differences between high‐and low‐middle‐income countries EM Bloch, R Goel, S Wendel, T Burnouf, AZ Al‐Riyami, AL Ang, ... Vox sanguinis 116 (1), 18-35, 2021 | 56 | 2021 |
| Assessment of HIV transfusion transmission risk in South Africa: a 10‐year analysis following implementation of individual donation nucleic acid amplification technology … M Vermeulen, N Lelie, C Coleman, W Sykes, G Jacobs, R Swanevelder, ... Transfusion 59 (1), 267-276, 2019 | 55 | 2019 |
| A mathematical model for estimating residual transmission risk of occult hepatitis B virus infection with different blood safety scenarios J Weusten, H van Drimmelen, M Vermeulen, N Lelie Transfusion 57 (3pt2), 841-849, 2017 | 39 | 2017 |
